CBPO - チャイナ・バイオロジック・プロダクツ (China Biologic Products Holdings Inc.) チャイナ・バイオロジック・プロダクツ

 CBPOのチャート


 CBPOの企業情報

symbol CBPO
会社名 China Biologic Products Inc (チャイナ・バイオロジック・プロダクツ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 チャイナ・バイオロジック・プロダクツ・ホールディングス(China Biologic Products Holdings Inc.)はバイオ製薬会社である。同社は中国においてヒト血漿ベースのバイオ医薬品の研究・開発・製造・販売に従事する。同社はヒト血漿製品の製造と販売を通じて事業を運営する。同社は20種類以上の血漿製品及び9種類の他のバイオ医薬品製剤を含む製品ポートフォリオを有する。同社の製品にはヒト・アルブミン、ヒト免疫グロブリン、静脈注射用免疫グロブリン(IVIG)、ヒトB型肝炎免疫グロブリン、ヒト狂犬病免疫グロブリン、ヒト破傷風免疫グロブリン、胎盤ポリペプチド、第VIII因子及びヒト・プロトロンビン複合体濃縮物(PCC)を含む。   チャイナ・バイオロジック・プロダクツは、中国のバイオ医薬品企業。ヒト血漿ベ―スの医薬品を開発、製造、販売を中国で従事する。主要製品は、ヒトアルブミンおよび免疫グロブリン製品。ドナ―から血漿を収集するプラズマステ―ションを所有・運営する。直接病院や接種センタ―に、または中国での代理店を通じて製品を販売する。   China Biologic Products Holdings, Inc. engages in the research, development, manufacture and sale of human plasma-based biopharmaceutical products or plasma products. Its products include plasma and other products. The company was founded in 2002 and is headquartered in Beijing, China.
本社所在地 18th Floor Jialong International Building 19 Chaoyang Park Road Chaoyang District Beijing 100125 CHN
代表者氏名
代表者役職名
電話番号 +86 10-6598-3111
設立年月日 32843
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 1799人
url www.chinabiologic.com
nasdaq_url https://www.nasdaq.com/symbol/cbpo
adr_tso
EBITDA EBITDA(百万ドル) ー
終値(lastsale) 77.86
時価総額(marketcap) 2605607557.26
時価総額 時価総額(百万ドル) 2645.836
売上高 売上高(百万ドル) --
企業価値(EV) 企業価値(EV)(百万ドル) 2279.6627
当期純利益 当期純利益(百万ドル) --
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 China Biologic Products Holdings Inc revenues increased 29% to $232.8M. Net income applicable to common stockholders increased 2% to $60.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Selling expenses increase from $7.4M to $45M (expense).

 CBPOのテクニカル分析


 CBPOのニュース

   Plasma Therapy Market 2020-2026 Refreshing Trends || Major Giants – Biotest AG., Cambryn Biologics, China Biologic Products Holdings, Inc., CSL Limited, DePuy Synthes  2020/09/28 19:06:58 OpenPR
A most recent review on Global Plasma Therapy Market is led covering different associations of the business from various topographies to think of 100+ page report. The examination is an ideal blend of subjective and quantitative data featuring key market
   Thinking about trading options or stock in Boeing, China Biologic Products, FedEx, Intel, or JPMorgan?  2020/04/08 13:31:00 PR Newswire
NEW YORK, April 8, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BA, CBPO, FDX, INTC, and JPM. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different…
   Hedge Funds Are Buying China Biologic Products Inc (CBPO)  2020/04/05 23:44:06 Yahoo Finance
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
   The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval  2019/11/15 12:08:29 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) 10X Genomics Inc (NASDAQ: TXG )(IPOed Sept. 12) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) China Biologic Products Holdings Inc (NASDAQ: CBPO )(reacted to its third-quarter results) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(priced its debt offering) IGM Biosciences Inc (NASDAQ: IGMS ) Kodiak Sciences Inc (NASDAQ: KOD ) Novo Nordisk A/S (NYSE: NVO ) Seattle Genetics, Inc. (NASDAQ: SGEN ) XOMA Corp (NASDAQ: XOMA ) XBiotech Inc (NASDAQ: XBIT ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 14) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Altimmune Inc (NASDAQ: ALT ) (reacted to its third-quarter results) Auris Medical Holding Ltd (NASDAQ: EARS ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) (priced its common stock offering) Cellectar Biosciences Inc (NASDAQ: CLRB ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc.
   Healthcare Stocks That Hit New Highs (CBPO, CNMD, BHC...)  2019/11/15 04:09:00 RTT News
The following are the healthcare stocks that hit a new 52-week high on Thursday..
   Thinking about trading options or stock in Boeing, China Biologic Products, FedEx, Intel, or JPMorgan?  2020/04/08 13:31:00 PR Newswire
NEW YORK, April 8, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BA, CBPO, FDX, INTC, and JPM. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different…
   Hedge Funds Are Buying China Biologic Products Inc (CBPO)  2020/04/05 23:44:06 Yahoo Finance
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
   The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval  2019/11/15 12:08:29 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) 10X Genomics Inc (NASDAQ: TXG )(IPOed Sept. 12) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) China Biologic Products Holdings Inc (NASDAQ: CBPO )(reacted to its third-quarter results) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(priced its debt offering) IGM Biosciences Inc (NASDAQ: IGMS ) Kodiak Sciences Inc (NASDAQ: KOD ) Novo Nordisk A/S (NYSE: NVO ) Seattle Genetics, Inc. (NASDAQ: SGEN ) XOMA Corp (NASDAQ: XOMA ) XBiotech Inc (NASDAQ: XBIT ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 14) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Altimmune Inc (NASDAQ: ALT ) (reacted to its third-quarter results) Auris Medical Holding Ltd (NASDAQ: EARS ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) (priced its common stock offering) Cellectar Biosciences Inc (NASDAQ: CLRB ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc.
   Healthcare Stocks That Hit New Highs (CBPO, CNMD, BHC...)  2019/11/15 04:09:00 RTT News
The following are the healthcare stocks that hit a new 52-week high on Thursday..
   The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing  2019/11/14 13:07:04 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Nov. 13.) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Bausch Health Companies Inc (NYSE: BHC ) BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) (reacted to its third-quarter results) Bristol-Myers Squibb Co (NYSE: BMY ) Celgene Corporation (NASDAQ: CELG ) China Biologic Products Holdings Inc (NASDAQ: CBPO ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Edwards Lifesciences Corp (NYSE: EW ) ESSA Pharma Inc (NASDAQ: EPIX ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) (reacted to its third-quarter results) IGM Biosciences Inc (NASDAQ: IGMS ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) ( reported an unexpected profit for its third quarter) Recro Pharma Inc (NASDAQ: REPH ) Seattle Genetics, Inc. (NASDAQ: SGEN ): filed an arbitration demand to settle dispute with DAIICHI SANKYO/S ADR (OTC: DSNKY ).
   Thinking about trading options or stock in Boeing, China Biologic Products, FedEx, Intel, or JPMorgan?  2020/04/08 13:31:00 PR Newswire
NEW YORK, April 8, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BA, CBPO, FDX, INTC, and JPM. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different…
   Hedge Funds Are Buying China Biologic Products Inc (CBPO)  2020/04/05 23:44:06 Yahoo Finance
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
   The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval  2019/11/15 12:08:29 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 14) 10X Genomics Inc (NASDAQ: TXG )(IPOed Sept. 12) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) China Biologic Products Holdings Inc (NASDAQ: CBPO )(reacted to its third-quarter results) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(priced its debt offering) IGM Biosciences Inc (NASDAQ: IGMS ) Kodiak Sciences Inc (NASDAQ: KOD ) Novo Nordisk A/S (NYSE: NVO ) Seattle Genetics, Inc. (NASDAQ: SGEN ) XOMA Corp (NASDAQ: XOMA ) XBiotech Inc (NASDAQ: XBIT ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 14) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Altimmune Inc (NASDAQ: ALT ) (reacted to its third-quarter results) Auris Medical Holding Ltd (NASDAQ: EARS ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) (priced its common stock offering) Cellectar Biosciences Inc (NASDAQ: CLRB ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cleveland BioLabs, Inc.
   Healthcare Stocks That Hit New Highs (CBPO, CNMD, BHC...)  2019/11/15 04:09:00 RTT News
The following are the healthcare stocks that hit a new 52-week high on Thursday..
   The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing  2019/11/14 13:07:04 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Nov. 13.) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Bausch Health Companies Inc (NYSE: BHC ) BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) (reacted to its third-quarter results) Bristol-Myers Squibb Co (NYSE: BMY ) Celgene Corporation (NASDAQ: CELG ) China Biologic Products Holdings Inc (NASDAQ: CBPO ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Edwards Lifesciences Corp (NYSE: EW ) ESSA Pharma Inc (NASDAQ: EPIX ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) (reacted to its third-quarter results) IGM Biosciences Inc (NASDAQ: IGMS ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) ( reported an unexpected profit for its third quarter) Recro Pharma Inc (NASDAQ: REPH ) Seattle Genetics, Inc. (NASDAQ: SGEN ): filed an arbitration demand to settle dispute with DAIICHI SANKYO/S ADR (OTC: DSNKY ).

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 チャイナ・バイオロジック・プロダクツ CBPO China Biologic Products Holdings Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)